Congrès  >   ECCO 2022  >  'Superdonor' Samples Don't Increase FMT Success in Ulcerative Colitis (ECCO 2022)

'Superdonor' Samples Don't Increase FMT Success in Ulcerative Colitis (ECCO 2022)

01/03 - The success of fecal microbiota transplantation (FMT) in people with active ulcerative colitis (UC) was not improved by using highly standardized and controlled "superdonor" samples versus control samples, according to results reported at the 17th congress of the European Crohn's and Colitis Organisation.

Vous désirez lire la suite de cet article ?

Inscrivez-vous gratuitement pour accéder à tous les contenus de Mediquality sur tous vos écrans.